MARKET

RVMDW

RVMDW

Revolution
NASDAQ
1.560
-0.030
-1.89%
After Hours: 1.620 +0.06 +3.85% 16:39 02/13 EST
OPEN
1.500
PREV CLOSE
1.590
HIGH
1.680
LOW
1.450
VOLUME
6.96K
TURNOVER
--
52 WEEK HIGH
3.590
52 WEEK LOW
0.0305
MARKET CAP
--
P/E (TTM)
-0.3013
1D
5D
1M
3M
1Y
5Y
1D
Royalty Pharma Q4 adjusted EBITDA beats analyst expectations
Reuters · 2d ago
Weekly Report: what happened at RVMDW last week (0202-0206)?
Weekly Report · 4d ago
REVOLUTION MEDICINES INC <RVMD.O>: LEERINK PARTNERS RAISES TARGET PRICE TO $115 FROM $74
Reuters · 02/05 12:09
U.S. RESEARCH ROUNDUP-Alphabet, Corteva, Varonis Systems
Reuters · 02/05 08:16
Revolution Medicines CEO to Join Guggenheim Securities Emerging Outlook Biotech Summit
Reuters · 02/04 21:05
Revolution Medicines nimmt am Guggenheim Securities Emerging Outlook: Biotech Summit teil
Reuters · 02/04 21:05
Weekly Report: what happened at RVMDW last week (0126-0130)?
Weekly Report · 02/02 10:39
REVOLUTION MEDICINES INC <RVMD.O>: JP MORGAN RAISES TARGET PRICE TO $122.00 FROM $92.00
Reuters · 02/02 04:27
More
About RVMDW
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. Its RAS Companion Inhibitors are designed primarily for combination treatment strategies centered on its RAS(ON) Inhibitors. The Company’s RAS(ON) Inhibitors RMC-6236 RMC-6291 and RMC-9805 are in clinical development. RMC-6236, its RASMULTI(ON) inhibitor, is designed as a potent, oral, RAS-selective tri-complex inhibitor of multiple RAS(ON) variants, including cancer drivers.

Webull offers Revolution Medicines Inc stock information, including NASDAQ: RVMDW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVMDW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVMDW stock methods without spending real money on the virtual paper trading platform.